|
WO2018100162A1
|
|
Orally dispersible tablet form of aripiprazole monohydrate formulations
|
|
WO2018099895A1
|
|
Solid oral pharmaceutical compositions comprising tenofovir and emtricitabine
|
|
EP3321211A1
|
|
Inhaler device comprising a fixable lid assembly
|
|
WO2018087185A1
|
|
Inhaler device with improved outer body
|
|
CN110430911A
|
|
The new-type guide gear of inhaler device
|
|
CA3043144A1
|
|
Inhaler device with improved locking clip
|
|
BR112018008083A2
|
|
tiotropium bromide inhalable blister
|
|
EP3159278A1
|
|
Blister for tiotropium bromide inhalable formulation
|
|
EP3070099A1
|
|
A process for preparing granulocyte colony stimulating factor (g-csf)
|
|
EP3025707A1
|
|
A multilayer tablet comprising metformin and pioglitazone
|
|
EP3166641A1
|
|
A process for the preparation of formulations for inhalation
|
|
UA117534C2
|
|
A process for the preparation of dry powder formulations
|
|
WO2016005447A1
|
|
A process for preparing the inhalation formulations
|
|
WO2016005434A1
|
|
Novel process for the preparation of dry powder formulations
|
|
EP2957552A1
|
|
Vilanterol formulations
|
|
EP2957550A1
|
|
Pharmaceutical formulations comprising vilanterol
|
|
EP2957553A1
|
|
Pharmaceutical formulations of vilanterol
|
|
EP2957551A1
|
|
Dry powder formulations comprising vilanterol
|
|
EP2929878A1
|
|
Extended release formulations of gabapentin
|
|
EP2821062A1
|
|
Novel dry powder inhaler formulations
|
